0000000000790002

AUTHOR

A Kemmer Brueck

showing 1 related works from this author

IVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma

2017

0301 basic medicinebusiness.industryMelanomaMutantPhases of clinical researchHematologyFirst in humanmedicine.disease03 medical and health sciences030104 developmental biologyOncologyCancer researchMedicinebusinessAnnals of Oncology
researchProduct